FISCHER — Fischer Medical Ventures Balance Sheet
0.000.00%
- IN₹31.18bn
- IN₹30.68bn
- IN₹1.11bn
Annual balance sheet for Fischer Medical Ventures, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.724 | 0.443 | 0.408 | 410 | 2,514 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | 1.71 | 229 | 1,042 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.774 | 0.493 | 2.48 | 704 | 3,653 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | — | — | 125 | 197 |
| Net Goodwill | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2.54 | 1.9 | 3.54 | 863 | 4,574 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.177 | 4.2 | 6.2 | 38.3 | 1,018 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.51 | 4.2 | 6.2 | 52.1 | 1,198 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.031 | -2.29 | -2.66 | 811 | 3,375 |
| Total Liabilities & Shareholders' Equity | 2.54 | 1.9 | 3.54 | 863 | 4,574 |
| Total Common Shares Outstanding |